Live market news
Stocks
HURA

TuHURA Biosciences Inc

HURAStockUSA

See in Charts

Latest news on HURAranked by Oyticker for market impact

45Impact
Positive5 Oct 2026 · 11:50 UTC · Global · Medium term
HURA Secures U.S. Patent for Delta Opioid Receptor ADC Technology Platform
TuHURA Biosciences obtained a U.S. patent covering its delta opioid receptor (DOR) antibody-drug conjugate (ADC) technology, protecting a novel mechanism for targeted oncology therapeutics. Patent grants extend intellectual property exclusivity for the company's Phase 3 pipeline.
HURABiotechnologyOncologyPharmaceuticals

SEC filings

What HURA filed

All its filings

6 Nov 2026
New debt or obligation (opens the document on sec.gov)8-K
16 Oct 2026
New debt or obligation (opens the document on sec.gov)8-K
24 Sept 2026
New debt or obligation (opens the document on sec.gov)8-K
17 Sept 2026
New debt or obligation (opens the document on sec.gov)8-K
17 Sept 2026
Executive or director change, amended (opens the document on sec.gov)8-K/A
16 Sept 2026
Executive or director change (opens the document on sec.gov)8-K
4 Sept 2026
New debt or obligation (opens the document on sec.gov)8-K
21 Aug 2026
New debt or obligation (opens the document on sec.gov)8-K
19 Aug 2026
Unregistered share sale (opens the document on sec.gov)8-K
Shareholder vote results
14 Aug 2026
Quarterly report (opens the document on sec.gov)10-Q
14 Aug 2026
Results announced (opens the document on sec.gov)8-K
13 Aug 2026
New debt or obligation (opens the document on sec.gov)8-K
29 Jul 2026
New debt or obligation (opens the document on sec.gov)8-K
9 Jul 2026
Proxy statement (opens the document on sec.gov)DEF 14A
7 Jul 2026
New debt or obligation (opens the document on sec.gov)8-K

From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.

Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.

Latest news on HURAranked by Oyticker for market impact

HURA Secures U.S. Patent for Delta Opioid Receptor ADC Technology Platform

What HURA filed